T. Rowe Price Associates, Inc. filed Amendment No. 2 to Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of 2,962,819 shares of Fabrinet common stock as of September 30, 2026.
Key Highlights
- Aggregate beneficial ownership: T. Rowe Price Associates reported beneficial ownership of 2,962,819 shares of Fabrinet common stock, representing 8.3% of the class.
- Sole voting power: The filing disclosed sole voting power over 2,856,017 shares.
- Sole dispositive power: T. Rowe Price reported sole dispositive power over all 2,962,819 shares.
- No shared power: Both shared voting power and shared dispositive power were reported as 0.
- Event date: The date of the event requiring this filing was September 30, 2026.
- Filer classification: T. Rowe Price Associates is identified as an investment adviser (type "IA"), organized in Maryland.
T. Rowe Price Discloses 8.3% Position in Fabrinet as of September 30, 2026
T. Rowe Price Associates, Inc., a Maryland-incorporated investment adviser headquartered at 1307 Point Street, Baltimore, MD 21231, submitted Amendment No. 2 to Schedule 13G disclosing its holdings in Fabrinet, whose principal executive offices are located at c/o Fabrinet USA, Inc., 4900 Patrick Henry Drive, Santa Clara, CA 95054. The filing covers common stock with CUSIP number G3323L100 and was signed by Ellen York, Vice President, on November 16, 2026.
According to the filing, T. Rowe Price Associates beneficially owned 2,962,819 shares as of September 30, 2026, equating to 8.3% of Fabrinet's outstanding common stock. Of that total, the firm reported sole voting power over 2,856,017 shares and sole dispositive power over the full 2,962,819 shares. Shared voting power and shared dispositive power were each reported as 0.
The filing includes a certification stating that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer." The filing also states that T. Rowe Price Associates "hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied."
What Was Disclosed
T. Rowe Price Associates, Inc. filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 2,962,819 shares, or 8.3%, of Fabrinet common stock as of September 30, 2026, with sole voting power over 2,856,017 of those shares.



Please wait processing your request...